Absol, a medical device used in the Enzyme Immunology Analysis (ELISA), one of the immune response tests for follow-up management after tumor diagnosis, is already attracting attention overseas due to its excellent cost-effectiveness. 

https://www.hankyung.com/finance/article/2019082974981 

Excerpt from hankyung